Pharmaceutical Drug Targets and Diseases
From Proteopedia
(Difference between revisions)
| Line 74: | Line 74: | ||
**Erectile Dysfunction | **Erectile Dysfunction | ||
***[[cGMP-Specific Phosphodiesterase Type 5]] | ***[[cGMP-Specific Phosphodiesterase Type 5]] | ||
| - | |||
| - | **HIV | ||
| - | ***[[Reverse Transcriptase]] | ||
**Hypertension & Congestive Heart Failure | **Hypertension & Congestive Heart Failure | ||
| Line 90: | Line 87: | ||
***[[Molecular_Playground/Human_Protective_Protein_Cathepsin_A|Protective Protein/Cathepsin A (PPCA) 2]] | ***[[Molecular_Playground/Human_Protective_Protein_Cathepsin_A|Protective Protein/Cathepsin A (PPCA) 2]] | ||
***[[Treatment_of_Gaucher_disease]] | ***[[Treatment_of_Gaucher_disease]] | ||
| - | |||
**Schizophrenia, Bipolar Depression, Insomnia, and Anxiety Disorders | **Schizophrenia, Bipolar Depression, Insomnia, and Anxiety Disorders | ||
| Line 97: | Line 93: | ||
***[[Histamine Receptor]] | ***[[Histamine Receptor]] | ||
***[[Opioid Receptor]] | ***[[Opioid Receptor]] | ||
| + | |||
| + | **Viruses | ||
| + | ***HIV | ||
| + | ****[[Reverse Transcriptase]] | ||
| + | ***Influenza | ||
| + | **** [[Avian Influenza Neuraminidase, Tamiflu and Relenza]] | ||
| + | **** [[Influenza hemagglutinin]] | ||
| + | **** [[Molecular_Playground/Influenza_A_M2_transmembrane_domain|Influenza A M2 Transmembrane Domain]] | ||
| + | **** [[Proton Channels]] featuring a morph of the M2 proton channel of influenza. | ||
| + | **** [[Molecular Playground/Tamiflu|Tamiflu]] | ||
| + | **** [[Molecular Playground/Relenza|Relenza]] | ||
}} | }} | ||
Revision as of 10:35, 24 September 2010
The following is a list of major pharmaceutical compound targets, organized by disease.
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Alexander Berchansky, Eran Hodis, Thomas J. Stout, Wayne Decatur
